Why Penn research powers many FDA-approved treatments On August 30, 2017, faculty and staff at the Perelman Center for Advanced Medicine gathered for a “flash mob” celebration of the the FDA approval of a Penn Medicine-developed personalized cellular immune therapy. (Image: Courtesy of Penn Medicine News) Why Penn research powers many FDA-approved treatments Since 2017, the FDA approved more than two dozen new therapies with roots at Penn Medicine—almost half of which are first-in-class for their indications.
Philadelphia life sciences jobs being filled more by women than men, study finds Penn In the News Philadelphia Business Journal Philadelphia life sciences jobs being filled more by women than men, study finds Jean Bennett, Katalin Karikó, and Drew Weissman of the Perelman School of Medicine are noted for their advancements in gene therapy and mRNA technology. Moderna, Merck show progress toward cancer vaccines Penn In the News The Wall Street Journal Moderna, Merck show progress toward cancer vaccines Robert Vonderheide of the Perelman School of Medicine says that a combined immunotherapy-vaccine approach could be a game changer for melanoma patients. In what could be a ‘big shift’ for cancer treatment, mRNA vaccine shows promise against melanoma Penn In the News USA Today In what could be a ‘big shift’ for cancer treatment, mRNA vaccine shows promise against melanoma According to Robert Vonderheide of the Perelman School of Medicine, the pandemic proved that mRNA vaccines could be used safely and developed quickly. Novel treatment shows promise against rare cancer in kids Penn In the News Associated Press Novel treatment shows promise against rare cancer in kids Carl June of the Perelman School of Medicine comments on the success of a new study using CAR-T cell therapy to combat tumors in children with a rare kind of cancer. Could the silver lining of the pandemic be pan-vaccines? Penn In the News The Hill Could the silver lining of the pandemic be pan-vaccines? Scott Hensley of the Perelman School of Medicine and colleagues have developed a vaccine that could provide a baseline level of protection against all 20 known flu strains. A potential strategy to improve T cell therapy in solid tumors Image: Courtesy of Penn Medicine News A potential strategy to improve T cell therapy in solid tumors A new Penn Medicine preclinical study finds that a new simultaneous “knockout” of two inflammatory regulators boosted T cell expansion to attach solid tumors. The next stage of COVID is starting now Penn In the News The Atlantic The next stage of COVID is starting now Scott Hensley of the Perelman School of Medicine says that children’s responses and vulnerability to future bouts of coronavirus may depend on the variants they encounter. U.S. focuses on limiting spread amid record bird flu season, but vaccines could be a possibility in the future Penn In the News CNN U.S. focuses on limiting spread amid record bird flu season, but vaccines could be a possibility in the future Scott Hensley of the Perelman School of Medicine and colleagues are developing a bird flu vaccine candidate that could be used in humans if the virus started circulating among people. Immunity from COVID-19 infection is strong and lasting, but carries risks, research finds Penn In the News Politifact Immunity from COVID-19 infection is strong and lasting, but carries risks, research finds According to John Wherry of the Perelman School of Medicine, it’s not surprising that SARS-CoV-2 infection generates robust immunity, including protection from disease. Load More
Moderna, Merck show progress toward cancer vaccines Penn In the News The Wall Street Journal Moderna, Merck show progress toward cancer vaccines Robert Vonderheide of the Perelman School of Medicine says that a combined immunotherapy-vaccine approach could be a game changer for melanoma patients. In what could be a ‘big shift’ for cancer treatment, mRNA vaccine shows promise against melanoma Penn In the News USA Today In what could be a ‘big shift’ for cancer treatment, mRNA vaccine shows promise against melanoma According to Robert Vonderheide of the Perelman School of Medicine, the pandemic proved that mRNA vaccines could be used safely and developed quickly. Novel treatment shows promise against rare cancer in kids Penn In the News Associated Press Novel treatment shows promise against rare cancer in kids Carl June of the Perelman School of Medicine comments on the success of a new study using CAR-T cell therapy to combat tumors in children with a rare kind of cancer. Could the silver lining of the pandemic be pan-vaccines? Penn In the News The Hill Could the silver lining of the pandemic be pan-vaccines? Scott Hensley of the Perelman School of Medicine and colleagues have developed a vaccine that could provide a baseline level of protection against all 20 known flu strains. A potential strategy to improve T cell therapy in solid tumors Image: Courtesy of Penn Medicine News A potential strategy to improve T cell therapy in solid tumors A new Penn Medicine preclinical study finds that a new simultaneous “knockout” of two inflammatory regulators boosted T cell expansion to attach solid tumors. The next stage of COVID is starting now Penn In the News The Atlantic The next stage of COVID is starting now Scott Hensley of the Perelman School of Medicine says that children’s responses and vulnerability to future bouts of coronavirus may depend on the variants they encounter. U.S. focuses on limiting spread amid record bird flu season, but vaccines could be a possibility in the future Penn In the News CNN U.S. focuses on limiting spread amid record bird flu season, but vaccines could be a possibility in the future Scott Hensley of the Perelman School of Medicine and colleagues are developing a bird flu vaccine candidate that could be used in humans if the virus started circulating among people. Immunity from COVID-19 infection is strong and lasting, but carries risks, research finds Penn In the News Politifact Immunity from COVID-19 infection is strong and lasting, but carries risks, research finds According to John Wherry of the Perelman School of Medicine, it’s not surprising that SARS-CoV-2 infection generates robust immunity, including protection from disease. Load More
In what could be a ‘big shift’ for cancer treatment, mRNA vaccine shows promise against melanoma Penn In the News USA Today In what could be a ‘big shift’ for cancer treatment, mRNA vaccine shows promise against melanoma According to Robert Vonderheide of the Perelman School of Medicine, the pandemic proved that mRNA vaccines could be used safely and developed quickly. Novel treatment shows promise against rare cancer in kids Penn In the News Associated Press Novel treatment shows promise against rare cancer in kids Carl June of the Perelman School of Medicine comments on the success of a new study using CAR-T cell therapy to combat tumors in children with a rare kind of cancer. Could the silver lining of the pandemic be pan-vaccines? Penn In the News The Hill Could the silver lining of the pandemic be pan-vaccines? Scott Hensley of the Perelman School of Medicine and colleagues have developed a vaccine that could provide a baseline level of protection against all 20 known flu strains. A potential strategy to improve T cell therapy in solid tumors Image: Courtesy of Penn Medicine News A potential strategy to improve T cell therapy in solid tumors A new Penn Medicine preclinical study finds that a new simultaneous “knockout” of two inflammatory regulators boosted T cell expansion to attach solid tumors. The next stage of COVID is starting now Penn In the News The Atlantic The next stage of COVID is starting now Scott Hensley of the Perelman School of Medicine says that children’s responses and vulnerability to future bouts of coronavirus may depend on the variants they encounter. U.S. focuses on limiting spread amid record bird flu season, but vaccines could be a possibility in the future Penn In the News CNN U.S. focuses on limiting spread amid record bird flu season, but vaccines could be a possibility in the future Scott Hensley of the Perelman School of Medicine and colleagues are developing a bird flu vaccine candidate that could be used in humans if the virus started circulating among people. Immunity from COVID-19 infection is strong and lasting, but carries risks, research finds Penn In the News Politifact Immunity from COVID-19 infection is strong and lasting, but carries risks, research finds According to John Wherry of the Perelman School of Medicine, it’s not surprising that SARS-CoV-2 infection generates robust immunity, including protection from disease. Load More
Novel treatment shows promise against rare cancer in kids Penn In the News Associated Press Novel treatment shows promise against rare cancer in kids Carl June of the Perelman School of Medicine comments on the success of a new study using CAR-T cell therapy to combat tumors in children with a rare kind of cancer. Could the silver lining of the pandemic be pan-vaccines? Penn In the News The Hill Could the silver lining of the pandemic be pan-vaccines? Scott Hensley of the Perelman School of Medicine and colleagues have developed a vaccine that could provide a baseline level of protection against all 20 known flu strains. A potential strategy to improve T cell therapy in solid tumors Image: Courtesy of Penn Medicine News A potential strategy to improve T cell therapy in solid tumors A new Penn Medicine preclinical study finds that a new simultaneous “knockout” of two inflammatory regulators boosted T cell expansion to attach solid tumors. The next stage of COVID is starting now Penn In the News The Atlantic The next stage of COVID is starting now Scott Hensley of the Perelman School of Medicine says that children’s responses and vulnerability to future bouts of coronavirus may depend on the variants they encounter. U.S. focuses on limiting spread amid record bird flu season, but vaccines could be a possibility in the future Penn In the News CNN U.S. focuses on limiting spread amid record bird flu season, but vaccines could be a possibility in the future Scott Hensley of the Perelman School of Medicine and colleagues are developing a bird flu vaccine candidate that could be used in humans if the virus started circulating among people. Immunity from COVID-19 infection is strong and lasting, but carries risks, research finds Penn In the News Politifact Immunity from COVID-19 infection is strong and lasting, but carries risks, research finds According to John Wherry of the Perelman School of Medicine, it’s not surprising that SARS-CoV-2 infection generates robust immunity, including protection from disease. Load More
Could the silver lining of the pandemic be pan-vaccines? Penn In the News The Hill Could the silver lining of the pandemic be pan-vaccines? Scott Hensley of the Perelman School of Medicine and colleagues have developed a vaccine that could provide a baseline level of protection against all 20 known flu strains. A potential strategy to improve T cell therapy in solid tumors Image: Courtesy of Penn Medicine News A potential strategy to improve T cell therapy in solid tumors A new Penn Medicine preclinical study finds that a new simultaneous “knockout” of two inflammatory regulators boosted T cell expansion to attach solid tumors. The next stage of COVID is starting now Penn In the News The Atlantic The next stage of COVID is starting now Scott Hensley of the Perelman School of Medicine says that children’s responses and vulnerability to future bouts of coronavirus may depend on the variants they encounter. U.S. focuses on limiting spread amid record bird flu season, but vaccines could be a possibility in the future Penn In the News CNN U.S. focuses on limiting spread amid record bird flu season, but vaccines could be a possibility in the future Scott Hensley of the Perelman School of Medicine and colleagues are developing a bird flu vaccine candidate that could be used in humans if the virus started circulating among people. Immunity from COVID-19 infection is strong and lasting, but carries risks, research finds Penn In the News Politifact Immunity from COVID-19 infection is strong and lasting, but carries risks, research finds According to John Wherry of the Perelman School of Medicine, it’s not surprising that SARS-CoV-2 infection generates robust immunity, including protection from disease. Load More
A potential strategy to improve T cell therapy in solid tumors Image: Courtesy of Penn Medicine News A potential strategy to improve T cell therapy in solid tumors A new Penn Medicine preclinical study finds that a new simultaneous “knockout” of two inflammatory regulators boosted T cell expansion to attach solid tumors.
The next stage of COVID is starting now Penn In the News The Atlantic The next stage of COVID is starting now Scott Hensley of the Perelman School of Medicine says that children’s responses and vulnerability to future bouts of coronavirus may depend on the variants they encounter. U.S. focuses on limiting spread amid record bird flu season, but vaccines could be a possibility in the future Penn In the News CNN U.S. focuses on limiting spread amid record bird flu season, but vaccines could be a possibility in the future Scott Hensley of the Perelman School of Medicine and colleagues are developing a bird flu vaccine candidate that could be used in humans if the virus started circulating among people. Immunity from COVID-19 infection is strong and lasting, but carries risks, research finds Penn In the News Politifact Immunity from COVID-19 infection is strong and lasting, but carries risks, research finds According to John Wherry of the Perelman School of Medicine, it’s not surprising that SARS-CoV-2 infection generates robust immunity, including protection from disease. Load More
U.S. focuses on limiting spread amid record bird flu season, but vaccines could be a possibility in the future Penn In the News CNN U.S. focuses on limiting spread amid record bird flu season, but vaccines could be a possibility in the future Scott Hensley of the Perelman School of Medicine and colleagues are developing a bird flu vaccine candidate that could be used in humans if the virus started circulating among people. Immunity from COVID-19 infection is strong and lasting, but carries risks, research finds Penn In the News Politifact Immunity from COVID-19 infection is strong and lasting, but carries risks, research finds According to John Wherry of the Perelman School of Medicine, it’s not surprising that SARS-CoV-2 infection generates robust immunity, including protection from disease. Load More
Immunity from COVID-19 infection is strong and lasting, but carries risks, research finds Penn In the News Politifact Immunity from COVID-19 infection is strong and lasting, but carries risks, research finds According to John Wherry of the Perelman School of Medicine, it’s not surprising that SARS-CoV-2 infection generates robust immunity, including protection from disease.